Registration Header Parameters

Normalized identity and public registration information from FDA records.

Source

FDA Device Registration & Listing

Record Type

Device registration/listing

Registration Number

3043050156

FEI Number

3043050156

Entity Name

GENESEEQ TECHNOLOGY INC.

City/State/Country

Toronto Ontario, CA

Establishment Address

1802-393 University Ave, Toronto Ontario M5G 1E6, CA

Establishment Type(s)

Develop Specifications But Do Not Manufacture At This Facility

Owner / Operator

Geneseeq Technology Inc. (Owner Number: 10094724)

Owner / Operator Contact Address

1802-393 University Ave, Toronto, CA-ON M5G 1E6, CA

Initial Importer Flag

Expiration Date (Year)

2026

510(k) Number

K250003

PMA Number

N/A

All Registered Proprietary Names

GENESEEQPRIME NGS Tumor Profiling Assay (FFPE)

Registered Product Listings

Product Code	Device Name	Medical Specialty	Device Class	Regulation Number	Created Date
PZM	Next Generation Sequencing Based Tumor Profiling Test	Pathology	Class 2	866.6080	2025-12-18

Official Correspondent

Lihua Wang

US Agent Details

Scott Bednar Business: QA/RA CONSULTING GROUP, INC. Email: sbednar@qaraconsultinggroup.com Phone: (412) 4188066

Related Public Records

Same Entity

Geneseeq Technology Inc.

View consolidated registration, premarket clearance, and recall records for this applicant.

View Entity Profile →

Similar Registrations

Registration Number	Establishment Name	Location
3043140667	GENESEEQ MEDICAL DEVICE AND DIAGNOSTIC INC.	Nanjing Jiangsu, CN
3013200421	TEMPUS AI, Inc.	Chicago, IL, US
3011805506	PERSONAL GENOME DIAGNOSTICS INC.	Baltimore, MD, US
3003335080	Life Technologies Corporation	FREDERICK, MD, US
3028606342	OMAY(GUANGZHOU) MED TECHNOLOGIES CO., LTD	Guangzhou Guangdong, CN

Source Citation & Summary: This public preview is extracted from openFDA device registration and listing logs under registration number 3043050156. Last updated year: 2026. Please use registration number 3043050156 when referencing this establishment in official correspondence.